These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2552768)

  • 1. The in vivo antiinflammatory effects of (E)-2,6-bis(1,1-dimethyl-ethyl)-4-[2-(5-methyl-1H-pyrazol-3-yl)ethenyl ] phenol (PD 127443) a novel dual inhibitor of 5-lipoxygenase and cyclooxygenase.
    Schrier DJ; Adamchak MA; Boctor AM; Kostlan CR; Flynn DL; Jordan JH; Lesch ME; Okonkwo GC
    Agents Actions; 1989 Jun; 27(3-4):391-4. PubMed ID: 2552768
    [No Abstract]   [Full Text] [Related]  

  • 2. SK&F 86002: a structurally novel anti-inflammatory agent that inhibits lipoxygenase- and cyclooxygenase-mediated metabolism of arachidonic acid.
    Griswold DE; Marshall PJ; Webb EF; Godfrey R; Newton J; DiMartino MJ; Sarau HM; Gleason JG; Poste G; Hanna N
    Biochem Pharmacol; 1987 Oct; 36(20):3463-70. PubMed ID: 2823821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacologic effects of 5-[3,5-bis(1,1-dimethylethyl)-4- hydroxyphenyl]-1,3,4-thiadiazole-2(3H)-thione, choline salt (CI-986), a novel inhibitor of arachidonic acid metabolism in models of inflammation, analgesia and gastric irritation.
    Schrier DJ; Baragi VM; Connor DT; Dyer RD; Jordan JH; Imre KM; Lesch ME; Mullican MD; Okonkwo GC; Conroy MC
    Prostaglandins; 1994 Jan; 47(1):17-30. PubMed ID: 8140259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor.
    Blackham A; Griffiths RJ; Hallam C; Mann J; Mitchell PD; Norris AA; Simpson WT
    Agents Actions; 1990 Jun; 30(3-4):432-42. PubMed ID: 2117338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ER-34122, a novel dual 5-lipoxygenase/cyclooxygenase inhibitor with potent anti-inflammatory activity in an arachidonic acid-induced ear inflammation model.
    Horizoe T; Nagakura N; Chiba K; Shirota H; Shinoda M; Kobayashi N; Numata H; Okamoto Y; Kobayashi S
    Inflamm Res; 1998 Oct; 47(10):375-83. PubMed ID: 9831321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.
    Argentieri DC; Ritchie DM; Ferro MP; Kirchner T; Wachter MP; Anderson DW; Rosenthale ME; Capetola RJ
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1399-408. PubMed ID: 7996452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of the inhibition of rat gastric mucosal 5-lipoxygenase by novel acetohydroxamic acids to prevent ethanol-induced damage.
    Boughton-Smith NK; Whittle BJ
    Br J Pharmacol; 1988 Sep; 95(1):155-62. PubMed ID: 3146394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsteroidal antiinflammatory drug hydroxamic acids. Dual inhibitors of both cyclooxygenase and 5-lipoxygenase.
    Flynn DL; Capiris T; Cetenko WJ; Connor DT; Dyer RD; Kostlan CR; Nies DE; Schrier DJ; Sircar JC
    J Med Chem; 1990 Aug; 33(8):2070-2. PubMed ID: 2115586
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacology of the dual inhibitor of cyclooxygenase and 5-lipoxygenase 3-hydroxy-5-trifluoromethyl-N-(2-(2-thienyl)-2-phenyl-ethenyl)-benzo (b)thiophene-2-carboxamide.
    Bailey PJ; Dallob AL; Allison DL; Anderson RL; Bach T; Durette PL; Hand KM; Hopple SL; Luell S; Meurer R
    Arzneimittelforschung; 1988 Mar; 38(3):372-8. PubMed ID: 3132928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the antiinflammatory activity of a dual cyclooxygenase-2 selective/5-lipoxygenase inhibitor, RWJ 63556, in a canine model of inflammation.
    Kirchner T; Argentieri DC; Barbone AG; Singer M; Steber M; Ansell J; Beers SA; Wachter MP; Wu W; Malloy E; Stewart A; Ritchie DM
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1094-101. PubMed ID: 9262379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of 5-lipoxygenase inhibitors and leukotriene antagonists on the development of gastric lesions induced by nonsteroidal antiinflammatory drugs in mice.
    Rainsford KD
    Agents Actions; 1987 Aug; 21(3-4):316-9. PubMed ID: 3687587
    [No Abstract]   [Full Text] [Related]  

  • 12. Antiinflammatory 2,6-di-tert-butyl-4-(2-arylethenyl)phenols.
    Lazer ES; Wong HC; Possanza GJ; Graham AG; Farina PR
    J Med Chem; 1989 Jan; 32(1):100-4. PubMed ID: 2491889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective inhibition of arachidonate 5-lipoxygenase by novel acetohydroxamic acids: effects on acute inflammatory responses.
    Higgs GA; Follenfant RL; Garland LG
    Br J Pharmacol; 1988 Jun; 94(2):547-51. PubMed ID: 2840161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arachidonic acid-induced pleurisy (ARIP): an in vivo model for testing 5-lipoxygenase inhibition.
    Boctor AM; Burke C; Hovinga ME
    Methods Find Exp Clin Pharmacol; 1987 Dec; 9(12):793-7. PubMed ID: 2831442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of experimental autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition.
    Prosiegel M; Neu I; Mallinger J; Wildfeuer A; Mehlber L; Vogl S; Hoffmann G; Ruhenstroth-Bauer G
    Acta Neurol Scand; 1989 Mar; 79(3):223-6. PubMed ID: 2541593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antiinflammatory action of guanabenz is mediated through 5-lipoxygenase and cyclooxygenase inhibition.
    Chang J; Blazek E; Skowronek M; Marinari L; Carlson RP
    Eur J Pharmacol; 1987 Oct; 142(2):197-205. PubMed ID: 3121363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of (2-fluoro-benzyl)-(2-methyl-2-phenethyl-2H-chromen-6-yl)-amine (KRH-102140) as an orally active 5-lipoxygenase inhibitor with activity in murine inflammation models.
    Cho YS; Song JS; Huh JY; Kim CH; Gong YD; Cheon HG
    Pharmacology; 2011; 87(1-2):49-55. PubMed ID: 21212714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 1,2-Dihydro-1-oxopyrrolo[3,2,1-kl]phenothiazine-2-carboxamides and congeners, dual cyclooxygenase/5-lipoxygenase inhibitors with antiinflammatory activity.
    Mylari BL; Carty TJ; Moore PF; Zembrowski WJ
    J Med Chem; 1990 Jul; 33(7):2019-24. PubMed ID: 2113951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice.
    Yamazaki R; Aiyama R; Matsuzaki T; Hashimoto S; Yokokura T
    Inflamm Res; 1998 Apr; 47(4):182-6. PubMed ID: 9628261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibition of arachidonic acid-induced ear edema in the mouse with lipoxygenase-, cyclo-oxygenase- and dual inhibitors].
    Zarnack S; Bekemeier H; Giessler AJ
    Pharmazie; 1988 May; 43(5):337-8. PubMed ID: 3140256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.